Literature DB >> 27979925

Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis.

Robert H Lee1, Raymond Piatt1, Pamela B Conley2, Wolfgang Bergmeier3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27979925      PMCID： PMC5394956          DOI： 10.3324/haematol.2016.155978

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

2.  Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice.

Authors:  Angèle Gros; Varouna Syvannarath; Lamia Lamrani; Véronique Ollivier; Stéphane Loyau; Tobias Goerge; Bernhard Nieswandt; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

3.  Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Andrew H Lipsky; Mohammed Z H Farooqui; Xin Tian; Sabrina Martyr; Ann M Cullinane; Khanh Nghiem; Clare Sun; Janet Valdez; Carsten U Niemann; Sarah E M Herman; Nakhle Saba; Susan Soto; Gerald Marti; Gulbu Uzel; Steve M Holland; Jay N Lozier; Adrian Wiestner
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

4.  Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.

Authors:  Christelle Nonne; Nadège Lenain; Béatrice Hechler; Pierre Mangin; Jean-Pierre Cazenave; Christian Gachet; François Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-17       Impact factor: 8.311

5.  Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.

Authors:  S Kamel; L Horton; L Ysebaert; M Levade; K Burbury; S Tan; M Cole-Sinclair; J Reynolds; R Filshie; S Schischka; A Khot; S Sandhu; M J Keating; H Nandurkar; C S Tam
Journal:  Leukemia       Date:  2014-08-20       Impact factor: 11.528

6.  Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition.

Authors:  T M Getz; R Piatt; B G Petrich; D Monroe; N Mackman; W Bergmeier
Journal:  J Thromb Haemost       Date:  2015-01-09       Impact factor: 5.824

7.  Platelet ITAM signaling is critical for vascular integrity in inflammation.

Authors:  Yacine Boulaftali; Paul R Hess; Todd M Getz; Agnieszka Cholka; Moritz Stolla; Nigel Mackman; A Phillip Owens; Jerry Ware; Mark L Kahn; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

8.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.

Authors:  Patrick Andre; Suzanne M Delaney; Thomas LaRocca; Diana Vincent; Francis DeGuzman; Marzena Jurek; Beverley Koller; David R Phillips; Pamela B Conley
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 9.  Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis.

Authors:  A I Schafer
Journal:  J Clin Pharmacol       Date:  1995-03       Impact factor: 3.126

10.  Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.

Authors:  Marie Levade; Elodie David; Cédric Garcia; Pierre-Alexandre Laurent; Sarah Cadot; Anne-Sophie Michallet; Jean-Claude Bordet; Constantine Tam; Pierre Sié; Loïc Ysebaert; Bernard Payrastre
Journal:  Blood       Date:  2014-10-10       Impact factor: 22.113
View more
  3 in total

1.  Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.

Authors:  Robert H Lee; Tomohiro Kawano; Steven P Grover; Vanthana Bharathi; David Martinez; Dale O Cowley; Nigel Mackman; Wolfgang Bergmeier; Silvio Antoniak
Journal:  J Thromb Haemost       Date:  2021-11-10       Impact factor: 5.824

2.  Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice.

Authors:  Jean Marie N Mwiza; Robert H Lee; David S Paul; Lori A Holle; Brian C Cooley; Bernhard Nieswandt; Wyatt J Schug; Tomohiro Kawano; Nigel Mackman; Alisa S Wolberg; Wolfgang Bergmeier
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

3.  Glycoprotein VI in securing vascular integrity in inflamed vessels.

Authors:  Yacine Boulaftali; Marie-Anne Mawhin; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Res Pract Thromb Haemost       Date:  2018-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.